Early nuclear phenotypes and reactive transformation in human iPSC-derived astrocytes from ALS patients with SOD1 mutations.
Vincent SoubannierMathilde ChaineauLale GursuSarah LépineDavid KalaydjianJulien SiroisGhazal HaghiGuy RouleauThomas M DurcanStefano StifaniPublished in: Glia (2024)
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by the progressive death of motor neurons (MNs). Glial cells play roles in MN degeneration in ALS. More specifically, astrocytes with mutations in the ALS-associated gene Cu/Zn superoxide dismutase 1 (SOD1) promote MN death. The mechanisms by which SOD1-mutated astrocytes reduce MN survival are incompletely understood. To characterize the impact of SOD1 mutations on astrocyte physiology, we generated astrocytes from human induced pluripotent stem cell (iPSC) derived from ALS patients carrying SOD1 mutations, together with control isogenic iPSCs. We report that astrocytes harboring SOD1(A4V) and SOD1(D90A) mutations exhibit molecular and morphological changes indicative of reactive astrogliosis when compared to isogenic astrocytes. We show further that a number of nuclear phenotypes precede, or coincide with, reactive transformation. These include increased nuclear oxidative stress and DNA damage, and accumulation of the SOD1 protein in the nucleus. These findings reveal early cell-autonomous phenotypes in SOD1-mutated astrocytes that may contribute to the acquisition of a reactive phenotype involved in alterations of astrocyte-MN communication in ALS.
Keyphrases
- amyotrophic lateral sclerosis
- dna damage
- oxidative stress
- induced pluripotent stem cells
- stem cells
- endothelial cells
- room temperature
- induced apoptosis
- cell proliferation
- ejection fraction
- gene expression
- mesenchymal stem cells
- bone marrow
- dna repair
- transition metal
- hydrogen peroxide
- risk assessment
- spinal cord injury
- drug induced
- pluripotent stem cells
- endoplasmic reticulum stress
- protein protein
- binding protein